Winter boots are difficult to pack, but their bulky size can be used to your advantage. Here's how to pack your boots for ...

At least 35 historically significant structures have been destroyed by the Eaton and Palisades fires, neither of which have ...

Lilly Pulitzer is serving up a Valentine’s Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

Heading into fiscal 2025, CEO David Ricks said the company expects sales of weight-loss drugs will continue growing, and noted that it expects "to produce at least 60% more salable doses" of the drugs ...

Lilly's stock went on a tear in the beginning of 2023, with the company's shares doubling as investors bet on the drug's popularity. The stock stumbled in October last year, after Zepbound's sales ...

Eli Lilly’s (LLY) shares slumped over 8% on Tuesday after the company projected fourth-quarter sales of its weight-loss drug Zepbound and diabetes treatment Mounjaro to fall short of Wall Street ...

Shares of Eli Lilly & Co. were headed for their worst day ... citing slower-than-expected growth in sales of its diabetes and weight-loss drugs. “While the U.S. incretin market grew 45% compared ...

Like many other biopharma companies presenting at this year’s J.P. Morgan Healthcare Conference, Eli Lilly took a chance on Tuesday to share its preliminary sales results for 2024. Unfortunately ...

Overall fourth-quarter sales are expected to be $13.5 billion, Lilly said in a statement of preliminary results, below the $14 billion average estimate of analysts surveyed by Bloomberg.